logo

Is papulopustular rosacea affecting your quality of life? If so, you may be interested in participating in our clinical trial for people 18 to 59 years old suffering from moderate to severe papulopustular rosacea. In doing so, you will help in getting new treatments into the hands of patients like you.

This local trial consists of applying an investigational topical gel treatment on the affected area twice daily. You will have a 2 in 3 chance of receiving the study treatment rather than placebo for the duration of the 12-week treatment period.

Compensation may be provided for time and travel. Participation in this study and access to the specialist physician will come at no cost to you. No medical insurance is required.

Select the site closest to your location below and complete the short questionnaire to see if you qualify! If you seem eligible, a member of the study team will contact you to review the study details further before you decide to participate.


Visits
Drug administered on which days
Total
Length
Procedures
Study Length
Days
Twice daily for 12 weeks
Total
6 visits
Length
Visits take approximately 60 minutes to 2.5 hours each, except for the screening visit which may take up to 3 hours.
Procedures
Blood draws, ECG, non-invasive skin biopsies, and optional medical photographs
Study Length
22 weeks
Summary
Clinical trial for people 18 to 59 years old suffering from moderate to severe papulopustular rosacea.
Condition
Rosacea
Treatment
TP-04

There are 3 locations for this study

K. Papp Clinical Research

K. Papp Clinical Research

Waterloo, Ontario, N2J 1C4, Canada
The Centre for Clinical Trials Inc.

The Centre for Clinical Trials Inc.

Oakville, Ontario, L6J 7W5, Canada
SKiN Center for Dermatology

SKiN Center for Dermatology

Peterborough, Ontario, K9J5K2, Canada
Rectangle 191

Are you a researcher or representative of a clinical site?

Join our network of clinical sites and be at the forefront of innovation in clinical research.